In 2002, Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Using adult mice.
Background: In the current study, they demonstrated that THC and other cannabinoids can induce apoptosis in murine and human leukemia and lymphoma cell lines as well as primary ALL cells. Responded to CB2 not CB1.
You can read the full article here => http://www.bloodjournal.org/content/100/2/627.long?sso-checked=true